Skip to main content
Log in

Induced bone marrow mesenchymal stem cells improve cardiac performance of infarcted rat hearts

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

We investigated whether transplantation of bone marrow mesenchymal stem cells (BMSC) with induced BMSC (iBMSC) or uninduced BMSC (uBMSC) into the myocardium could improve the performance of post-infarcted rat hearts. BMSCs were specified by flowcytometry. IBMSCs were cocultured with rat cardiomyocyte before transplantation. Cells were injected into borders of cardiac scar tissue 1 week after experimental infarction. Cardiac performance was evaluated by echocardiography at 1, 2, and 4 weeks after cellular or PBS injection. Langendorff working-heart and histological studies were performed 4 weeks after treatment. Myogenesis was detected by quantitative PCR and immunofluorescence. Echocardiography showed a nearly normal ejection fraction (EF) in iBMSC-treated rats and all sham control rats but a lower EF in all PBS-treated animals. The iBMSC-treated heart, assessed by echocardiography, improved fractional shortening compared with PBS-treated hearts. The coronary flow (CF) was decreased obviously in PBS and uBMSC-treated groups, but recovered in iBMSC-treated heart at 4 weeks (P < 0.01). Immunofluorescent microscopy revealed co-localization of Superparamagnetic iron oxide (SPIO)-labeled transplanted cells with cardiac markers for cardiomyocytes, indicating regeneration of damaged myocardium. These data provide strong evidence that iBMSC implantation is of more potential to improve infarcted cardiac performance than uBMSC treatment. It will open new promising therapeutic opportunities for patients with post-infarction heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Yoon J, Choi SC, Park CY et al (2008) Bone marrow-derived side population cells are capable of functional cardiomyogenic differentiation. Mol Cells 25:216–223

    PubMed  CAS  Google Scholar 

  2. van Dijk A, Niessen HW, Zandieh Doulabi B, Visser FC, van Milligen FJ (2008) Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell Tissue Res 334:457–467

    Article  PubMed  Google Scholar 

  3. Tateishi K, Takehara N, Matsubara H, Oh H (2008) Stemming heart failure with cardiac- or reprogrammed-stem cells. J Cell Mol Med 12:2217–2232

    Article  PubMed  CAS  Google Scholar 

  4. Breitbach M, Bostani T, Roell W et al (2007) Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110:1362–1369

    Article  PubMed  CAS  Google Scholar 

  5. Carr CA, Stuckey DJ, Tatton L et al (2008) Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. Am J Physiol Heart Circ Physiol 295:H533–H542

    Article  PubMed  CAS  Google Scholar 

  6. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW (2004) Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109:3154–3157

    Article  PubMed  Google Scholar 

  7. Hahn JY, Cho HJ, Kang HJ et al (2008) Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 51:933–943

    Article  PubMed  CAS  Google Scholar 

  8. Haider HKh, Ashraf M (2010) Preconditioning and stem cell survival. J Cardiovasc Transl Res 3:89–102

    Article  PubMed  Google Scholar 

  9. Cui X, Wang H, Guo H et al (2010) Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats. Tohoku J Exp Med 220:139–147

    Article  PubMed  CAS  Google Scholar 

  10. Ye NS, Chen J, Luo GA, Zhang RL, Zhao YF, Wang YM (2006) Proteomic profiling of rat bone marrow mesenchymal stem cells induced by 5-azacytidine. Stem Cells 15:665–676

    Article  CAS  Google Scholar 

  11. Tan G, Shim W, Gu Y et al (2010) Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells. Differentiation 79:260–271

    Article  PubMed  CAS  Google Scholar 

  12. Li XH, Yu XY, Lin QX et al (2007) Bone marrow mesenchymal stem cells differentiate into cardiac phenotype by microenvironment inducement without cell-to-cell physical touch. J Mol Cell Cardiol 42:295–303

    Article  PubMed  CAS  Google Scholar 

  13. Li XH, Yu XY, Lin QX et al (2008) Human bone marrow mesenchymal stem cells differentiate into cardiomyocyte phenotype in microenvironment. Chin J Cardiol 36:651–654

    CAS  Google Scholar 

  14. Reinecke H, Zhang M, Bartosek T, Murry CE (1999) Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation 100:193–202

    PubMed  CAS  Google Scholar 

  15. Fu YH, Lin QX, Li XH et al (2009) A novel rat model of chronic heart failure following myocardial infarction. Methods Find Exp Clin Pharmacol 31:367–373

    PubMed  CAS  Google Scholar 

  16. Qiao H, Zhang H, Zheng Y et al (2009) Embryonic stem cell grafting in normal and infarcted myocardium: serial assessment with MR imaging and PET dual detection. Radiology 250:821–829

    Article  PubMed  Google Scholar 

  17. Liu ZY, Wang Y, Liang CH et al (2009) In vitro labeling of mesenchymal stem cells with superparamagnetic iron oxide by means of microbubbleenhanced US exposure: initial experience. Radiology 253:153–159

    Article  PubMed  Google Scholar 

  18. Walczak P, Ruiz-Cabello J, Kedziorek DA et al (2006) Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine 2:89–94

    Article  PubMed  CAS  Google Scholar 

  19. Yagi H, Soto-Gutierrez A, Parekkadan B et al (2010) Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant 19:667–679

    Article  PubMed  Google Scholar 

  20. Herrero C, Pérez-Simón JA (2010) Immunomodulatory effect of mesenchymal stem cells. Braz J Med Biol Res 43:425–430

    Article  PubMed  CAS  Google Scholar 

  21. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439–1441

    Article  PubMed  Google Scholar 

  22. Caspi O, Huber I, Kehat I et al (2007) Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50:1884–1893

    Article  PubMed  Google Scholar 

  23. Haider HKh, Jiang S, Idris NM, Ashraf M (2008) IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ Res 103:1300–1308

    Article  PubMed  CAS  Google Scholar 

  24. Okada M, Payne TR, Zheng B et al (2008) Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol 52:1869–1880

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The project was supported by Grants from National Natural Science Foundation of China (Nos. 30900610, 30672077, 30772142), the National Key Basic Research Program (NKBRP) of China (No. 2006CB503806) and Guangdong Provincial Natural Science Foundation (Nos. 9451008002003467, 8251008004000001, 06020831, 06020821).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xi-Yong Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, XH., Fu, YH., Lin, QX. et al. Induced bone marrow mesenchymal stem cells improve cardiac performance of infarcted rat hearts. Mol Biol Rep 39, 1333–1342 (2012). https://doi.org/10.1007/s11033-011-0867-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-0867-2

Keywords

Navigation